CoreCap Advisors’s Disc Medicine IRON Stock Holding History

CoreCap Advisors’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.71K	Buy	+78	New	+$5.36K	﹤0.01%	2253
2025 Q2	–	Sell	-9	Closed	-$447	–	3001
2025 Q1	$447	Sell	9 -19	-68%	-$1.06K	﹤0.01%	2722
2024 Q4	$1.77K	Buy	+28	New	+$1.62K	﹤0.01%	2262

Other funds holding IRON

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Eleva Capital Paris, France $343M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

CoreCap Advisors's IRON Position: Q2 2026 in Review

CoreCap Advisors opened a new position in Disc Medicine (IRON) in Q2 2026: 78 shares worth $5.71K. The stake represents ﹤0.01% of the portfolio and ranks #2253 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in IRON as recently as Q1 2025.

CoreCap Advisors first reported a position in IRON in Q4 2024 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

CoreCap Advisors held 78 shares of Disc Medicine worth $5.71K as of Q2 2026.
Disc Medicine was a new CoreCap Advisors position in Q2 2026.
Disc Medicine made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2253 holding.
CoreCap Advisors first reported a position in Disc Medicine in Q4 2024 and has held it in 3 quarters since.
9 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.